JENLOGA

Welcome to the Brand page for “JENLOGA”, which is offered here for Pharmaceutical products, in the form of an extended release oral dosage for the treatment of hypertension, attention deficit hyperactivity disorders and other disorders characterized by excessive autonomic hyperactivity;.

Its status is currently believed to be active. Its class is unavailable. “JENLOGA” is believed to be currently owned by “SCIELE PHARMA, INC.”